Lack of association between HL-A antigens and measles antibody in multiple sclerosis

Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease.

Diabetes·1997

[Microbial safety of blood products].

Infusionstherapie und Transfusionsmedizin·1996

Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin.

Gut·1995

Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis.

Diabetologia·1995

Circulating forms of ICAM-3 (cICAM-3). Elevated levels in autoimmune diseases and lack of association with cICAM-1.

Journal of immunology (Baltimore, Md. : 1950)·1995

High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease.

Digestion·1995

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Current landscape of drug induced retinal vasculitis.

Journal of ophthalmic inflammation and infection·2026

Recent developments in the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.

Expert review of gastroenterology & hepatology·2026

AA Renal amyloidosis associated with a gastrointestinal stromal tumor.

Nefrologia·2026

Hyperinflammatory syndromes in primary mitochondrial disease: A three-center case series and focused review.

Molecular genetics and metabolism·2026

IL-15 drives antigen-independent increase in granzyme K+B+ CD8 T cells enriched in rheumatoid arthritis joints.

Journal of autoimmunity·2026

Re-evaluating the role of IL-1Ra gene therapy in knee osteoarthritis: a case for autologous conditioned serum as a practical alternative.

Connective tissue research·2026

Related Experiment Videos

Lack of association between HL-A antigens and measles antibody in multiple sclerosis

Related Concept Videos

Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease.

[Microbial safety of blood products].

Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin.

Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis.

Circulating forms of ICAM-3 (cICAM-3). Elevated levels in autoimmune diseases and lack of association with cICAM-1.

High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Current landscape of drug induced retinal vasculitis.

Recent developments in the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.

AA Renal amyloidosis associated with a gastrointestinal stromal tumor.

Hyperinflammatory syndromes in primary mitochondrial disease: A three-center case series and focused review.

IL-15 drives antigen-independent increase in granzyme K+B+ CD8 T cells enriched in rheumatoid arthritis joints.

Re-evaluating the role of IL-1Ra gene therapy in knee osteoarthritis: a case for autologous conditioned serum as a practical alternative.

Related Experiment Videos

Lack of association between HL-A antigens and measles antibody in multiple sclerosis

Related Concept Videos

Related Articles